Menu
Recruiting NCT06219486

The Safe Fast Track Study

No phase Interventional Emergency Department Non-specific Complaints

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: D-dimer.
Who it may be relevant to
Registry conditions: Emergency Department, Non-specific Complaints. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Denmark
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Use of D-dimers in the Emergency Department to Identify Adult Patients at Very Low Risk of Mortality for Fast-track Treatment - a Randomized Controlled Study

Overview

Emergency departments (ED) internationally are treating an increasing number of patients. Most require hospital services but some could be better cared for on alternative pathways. D-dimer has some unique properties. It is non-specific and is elevated in many acute condi- tions; but conversely remains normal in the absence of significant disease. Previous studies have shown that having a normal D-dimer on arrival to the emergency department is associated with a very low risk of 30-day all-cause mortality. The investigators propose a multicenter randomized controlled trial using D-dimer to identify patients at low risk and test if providing this information will change time to discharge disposition by the treating physician.

Interventions

  • Diagnostic test D-dimer
    The investigators will measure a D-dimer test on participants and randomize on informing the physician on the value.

Primary outcome measures

  • Length of stay [Time frame: From arrival to physician decision within 4 hours of arrival]
Secondary outcome measures (3)
  • 7- and 30-day all-cause mortality from arrival [Time frame: From arrival until 30-days later]
  • Hospital length of stay [Time frame: From arrival until final discharge within 1 month]
  • Re-contacts to the emergency department within 30 days from arrival for any reason [Time frame: From arrival until 30-days later]

Eligibility criteria

Inclusion criteria

  • Age 18 or above
  • Able to provide oral and written informed consent in Danish
  • Blood tests ordered on arrival as part of standard of care
  • Ambulatory on arrival or walking to the ambulance (i.e., stable independent gait)
  • Normal vital signs (i.e., National Early Warning Score \< 3)

Exclusion criteria

  • Unstable condition requiring immediate care in the resuscitation area
  • Triage level red (i.e., the most urgent patients)
  • Trauma (minor and major) patients
  • High likelihood of requiring a D-dimer analysis on clinical indications during the current hospital contact (e.g., suspected venous thromboembolic disease) that will be ordered on arrival regardless of this study
  • Previous participation in the study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Other

Study locations

Denmark · 2 centers
  • Esbjerg Hospital — Esbjerg
  • Odense University Hospital — Odense

Identifiers

NCT: NCT06219486 · The SafeFT-study

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗